Skip to main
University-wide Navigation

Markesbery Scientific Symposium and Poster Session Set for Nov. 6

Guest speaker Adam Brickman, professor of Neuropsychology, Columbia University, as well as research updates from Sanders-Brown Center on Aging.

$2.8 Million Grant Will Fund Preclinical Study of New Dementia Treatment

The research is novel in that it is exploring efficacy in treating more than one form of dementia at the same time. 

Conference Looks at Neurological Issues in the Pregnant Patient

The UK College of Medicine will host the 2019 Obstetrical Neurology Conference on Friday, Sept. 6, 2019 for faculty, providers and trainees in neurology, obstetrics, anesthesia and women's health interested in neurological issues in the pregnant patient.

Research Volunteers Drive Discoveries at Sanders-Brown Center on Aging

Thanks to volunteers, SBCoA has played a role in many landmark discoveries, including debunking the theories that aluminum or mercury cause Alzheimer's, identifying so-called "AD mimics", and proving that there are changes in the brain decades before there are outward symptoms of AD.

Preclinical Study of Therapeutic Strategy for Lafora Disease Shows Promise

A team of scientists have designed and tested a novel and promising therapeutic strategy for treating Lafora Disease (LD), a fatal form of childhood epilepsy.

UK Awarded $6 Million from NIH to Study Decision-Making Processes Behind Substance Use Disorders

Faculty from the Dept of Psychology in the College of Arts & Sciences and Behavioral Science in the College of Medicine have received two, five-year Research Project Grants from the NIH to study neurobehavioral processes involved in drug use disorders.

Behind the Blue: Sanders-Brown Director Linda Van Eldik Looks to the Future of Alzheimer's Research

In this episode of "Behind the Blue," Sanders-Brown director Linda Van Eldik talks about the center's involvement in some of the most important discoveries in the history of Alzheimer's research and what they are doing now to advance the science.

When is Alzheimer's Not Alzheimer's? Researchers Characterize a Different Form of Dementia

In the past, using "Alzheimer’s disease" & "dementia" interchangeably was a generally accepted practice. Now there's rising appreciation that a variety of diseases & disease processes contribute to dementia.

A Low Dose Aspirin for Dementia? Drug Ready for Human Testing

Linda Van Eldik, director of the UK Sanders-Brown Center on Aging, received $5.5 million from NIH and the Alzheimer's Drug Discovery Foundation. She developed a drug that is ready for its first round of testing in humans.

Does Smoking Cause Dementia? Maybe Not, Study Says

It's an irrefutable fact that smoking is bad for you. Study after study has proven that smoking increases your risk for cancer, heart disease, diabetes – even blindness. But dementia? Not so fast. A recent study has demonstrated that smoking is not associated with a higher risk of dementia.

Filter News